{"name":"Everest Medicines (China) Co.,Ltd.","slug":"everest-medicines-china-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxOVG9DYktxWkVidFZVNkhNN1luUzBuSUNrZlFIei1qeHQ3Sl9DVEhudDNmNVVDemVBX2pScnFaRkVrRm12NUNram9MQkRQVTFDMXZWY3lOYkw4bW5JWjJFTWl4dHEzV3cwSEhjbFNCcUdSbTZvbWYyUnVkZWdmNndVUXA1VmhicWZZc3ZIWVdjN3RVdE5zZUNRY2RtSVk1eUpiQ0s1T2s0cExzRU9hbHpMWFZPOVVJWnVaaTUzbC05Umh4ZVc0c0ZCeEtYTEhtRnRFWlBEVGtBNkVsdmFz?oc=5","date":"2026-03-23","type":"deal","source":"BioPharma APAC","summary":"Everest Medicines Acquires CARDAMYST Rights To Strengthen Cardiovascular Portfolio In Greater China - BioPharma APAC","headline":"Everest Medicines Acquires CARDAMYST Rights To Strengthen Cardiovascular Portfolio In Greater China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQNTRZQTkwWDNVbFFyNHRTcExMTGdBdC1EbjlwZWFnbFUyTUticFo4MUNvd29VaFJkSHFpQmowNmpNT3F6amdmbFNrVU9Lb2VQQWJoSVFPRVY2MTZnY1RMWjFjMXJWbVczVHN4TXB4Vnp3THQ3MzNfZHhWWWN3V1l3WDBWVTN2Q0t1bTFWWk5yb1h3VW53c2VaUUxVMmtmX0RTc1Y0d3RVMjBaZ1NLNmY1c3M0c0RFYjA?oc=5","date":"2026-02-09","type":"regulatory","source":"thebambooworks.com","summary":"BRIEF: Everest Medicines advances with major licensing deal, new drug application approval - thebambooworks.com","headline":"BRIEF: Everest Medicines advances with major licensing deal, new drug application approval","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOaFB6SVBtbFF6NmM5TnQ5UlVWdGF3ZFhaVFVOZHk0a2JrbXNYQ1pSVnU4MkdnVlI1VFRwWkN6UVFubjlBSEhpNEdsbG5fbTVyZ3RsUkJVMlRkdWppMkotN09wNl9Rem53UzgyODlnT18tcHFGY1B4cUJJSWpaNGtwTm9KRTREQ2ozNDB2STJKamM0a2J4MW9kQjRzOHVrNnV5VlZENDJGaHg5SFRtVV83QzNKWjBDMlRlZkg4RGxvZHRUTDJ0eFgw?oc=5","date":"2025-12-31","type":"pipeline","source":"Yicai Global","summary":"Everest Medicines Slides After Chinese Drugmaker's Kidney Disease Treatment Is Replicated - Yicai Global","headline":"Everest Medicines Slides After Chinese Drugmaker's Kidney Disease Treatment Is Replicated","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPWmhIMHlsWkhJbDMtVy13bmtpMGkxdGJWYTlxZXFBVkxFYjhQVWU3cGJkMDNhdVM2Q3dUcktGM0h0dHMwUmdlYUpPV1R3emlxMjExUFJ0S2Y3U2l6ZXk5WFQ0SzAtOE5sYUxWbjBJY3VkSV9XMnNpTGRyOHJiMVJLbTZNQW9aeGdESmM1bU9JLWsyT0xINVZjY2RWTTlMLUxVRFdJVGdORlY5Z2s2NXNkVFRtYkdhWmJxMzYw?oc=5","date":"2025-12-18","type":"regulatory","source":"BioPharma APAC","summary":"Everest Medicines Secures FDA Approval For LEROCHOL In Hypercholesterolemia - BioPharma APAC","headline":"Everest Medicines Secures FDA Approval For LEROCHOL In Hypercholesterolemia","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNRlZiYVBhNG5kWkZnUm9hVUxZWFNybnBCSXZ5M2J0bllWT3VwZmpFYktlOU1QRFc4YWJ6SG9UWXBQbTlNZzFmMW44WDBqcWc2cmgxV1AwT1ZmLUFteS1GbHFibUhZWVdkeFNva09uX3JBSUswT2ZXSFM4eF9tZWZVRkk2dmMzdDBSX0o1N1hnaEs1QVhqRS1TUk81UVgxeGNUQlg3Ykx1QzNjVjZ0TXg0RlZscmc4NmFMRGttTkpfaTJBMHJhMjZyeGhVc1M?oc=5","date":"2025-12-15","type":"pipeline","source":"BioPharma APAC","summary":"Everest Medicines Enters Dual Strategic Agreements with Hasten to Drive Accretive Growth - BioPharma APAC","headline":"Everest Medicines Enters Dual Strategic Agreements with Hasten to Drive Accretive Growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxPTWZUT2JDdTdGWTJPb0x1SEt5WXJQUGtDV2tQcnZ1OXNuMnFvbmtkUGxMVk5xQWM2bUVVbUU0UUFfbkRBSmJvSjlsS2loUGdVZjRHNEhSN0JpVFl0c0hGVHBlTjZTaHRZRUJ0WGVlMllYWTNNWmkwSmQ0WlR4MWhNQ09Oc250b0x0Z2llNFp0TTZPSEo5eFp2TVRPVldiejlKUUpzcGZwT0tDaEhYZXRtYmZlQmNqNjVseFllcFJONUF5WHBQbjJvOVdUdm1nd0NfTVV0OHk0VXZMWWlDV294VlVRMHlMOVQwYjhDRlB2WFc?oc=5","date":"2025-10-31","type":"deal","source":"BioPharma APAC","summary":"Everest Medicines Expands into Ophthalmology with Exclusive License for VIS-101 from Visara, a NovaBridge Subsidiary - BioPharma APAC","headline":"Everest Medicines Expands into Ophthalmology with Exclusive License for VIS-101 from Visara, a NovaBridge Subsidiary","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE83cGl3YlhiVjhLS2JJMVFDMm9Tcmc2R1BkQUdCWUNONHhGOGppZE9pYWtVYzRpVE9WOThSYjhxc1k0V1VQRnJFOVhtaTItVkh1bmloaGszU3hyZ2NDWmlDY1o0MEM1M2RYS3FFLXoyZjVKR3NwX3c?oc=5","date":"2025-09-24","type":"pipeline","source":"fortunebusinessinsights.com","summary":"Tetracyclines Market Size, Share | Growth Report [2034] - fortunebusinessinsights.com","headline":"Tetracyclines Market Size, Share | Growth Report [2034]","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQa0Z3bTNlZUFPVFhsU0o0RnFLSTRTQmhHSG4tRzBLS3Z1VkszeW9YNTdoVDc5M0xLZDlRVTNXcGtPWHhUd2pKdVBiZ0FwQWV0QU5HSEVyU2JKYmRjZnE0Q0FvSVFkLVNOVnd0ejlLWVZGc0RVTkRhWU5IVHRJQ0NlMUZBd1Rqal9aUVFVRFAtUQ?oc=5","date":"2025-08-01","type":"pipeline","source":"Contract Pharma","summary":"Everest Medicines Invests $30.9M in I-Mab - Contract Pharma","headline":"Everest Medicines Invests $30.9M in I-Mab","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNZ3oyZEVZdkFkT3hDb0xwVDdUbzh3RnlhVGdVSEJTVlU0OERkMm03S0JRUWRFcjBaekFOcEgtbmhGVWlIQkYtY3Y4ajZDV0pSMUtOSkp1TTFuejU0RnM2LVVvSFFnLV9xelpSQUFUbk95VURGUWRiREswblZQeExaUmJQd0xxbFlqQVVuQ21ELThIdTJ2SWhFNQ?oc=5","date":"2025-07-03","type":"pipeline","source":"24/7 Wall St.","summary":"5 Undervalued Chinese Stocks To Look at Right Now - 24/7 Wall St.","headline":"5 Undervalued Chinese Stocks To Look at Right Now - 24/7 Wall St.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPOGlzb0VWQnJMOWNReXp6OEEzcG9YSzhfYm9KX2hZWnVqMmtHTDZ6NHFOMzZncC1mRGtnLWpSRGIxWk5yUVJqeUNaVVpGSExUcWRTR201NEVTbmQwUVNZQXMwQ0RQaFlCOVNUeWdFZy0xSFR4VU9RX2l3VjQwcHFwTkNkMTdWaDdyX0hIcjV4U2JGcFZsWXBaaEdrSU1oZl9FNmFqRG5UaWNHSjFpYXZXY0Z1ZzJRQWVo?oc=5","date":"2022-12-22","type":"regulatory","source":"Pharmafile","summary":"Everest Medicines and licensing partner Pfizer receive FDA and EMA approval for ulcerative colitis drug - Pharmafile","headline":"Everest Medicines and licensing partner Pfizer receive FDA and EMA approval for ulcerative colitis drug","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxNUkNUb2kzeXpzdEhXSW9HUGljNVU2V29NN2kzN296XzhQSmV4N2k3ZkVnOGlydy1TV0xBdVYyV3E5S0o1elJhb1ZjWS0wRzhGSmZBc1ZLX04tMktfeXRHQzZOQWpRM0NBTWRvUDhMS3pMODlvWTBCZy1nNlFYbFpGeEhGbDFXWHhPZUZFdU4zY3B3d3ZHd0VuTWlwek81TWt5OU5BZTVPRGM0QmZOOU41U0I4OHRjUHpLWUlseFdvUTNrZkVIR1dxY3ZMc3Rtdw?oc=5","date":"2020-06-04","type":"pipeline","source":"GlobeNewswire","summary":"Everest Medicines Completes US$310 Million Series C Financing - GlobeNewswire","headline":"Everest Medicines Completes US$310 Million Series C Financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxQRGVsdVZIdmhzSEtoSXFsMUdMX05JbUo0NTR6NGhmV0l6WXcxVmgzSXZ1X3luMHVhMGk3VTFrbG1VM1RlZTU2Slhab3hrQlFCdG9UTDdaeGJMcWtyaFROaVQ0ZnViNVpMdkdPejdnT0tGY3dzVEI0MnNSamo4bE9uRnJOdGtpX215UkIzU1JzRmZFMzRkT2pMcXgzQ3JBNGJTa25MS2JOUmJLUGpQdnB5Y0RRQW9vc0ExY1lOcjRNWWpUV29vbFZwbFhsQVF3bjlFWksyNWRwamJmNDROUmpZeW9IelE0S3p1c0lPZW5pUXM0MHpTV2VYMGw2a2dGRnRkNHFYVm1xbkhpTHNxOXlUdXBvM3V5a3B3d1lDM2tn?oc=5","date":"2017-12-05","type":"deal","source":"PR Newswire","summary":"Arena Pharmaceuticals and Everest Medicines Enter into Development and Commercialization Partnership for Ralinepag and Etrasimod in China - PR Newswire","headline":"Arena Pharmaceuticals and Everest Medicines Enter into Development and Commercialization Partnership for Ralinepag and E","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}